<?xml version="1.0" encoding="UTF-8" ?><dbgapss xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="dbgapssws.1.0.xsd"><Study uid="30598" whole_study_id="30598" phs="001688" v="1" p="1" createDate="2018-07-18T11:23:21-05:00" completedByGPADate="2018-08-08T13:46:36-05:00" modDate="2020-07-08T08:50:08-05:00" maxParentChildStudyModDate="2020-07-08T08:50:08-05:00" handle="Psoriasis_Secukinumab" num_participants="35"><StudyInfo accession="phs001688.v1.p1" parentAccession="phs001688.v1.p1"><BioProject id="PRJNA490231" entrez_id="490231" type="bp_admin_access"/><BioProject id="PRJNA490232" entrez_id="490232" type="bp_data_submission"/><StudyNameEntrez>Microarray Gene Expression Data from Early Skin Biopsies of a Secukinumab Clinical Trial in Psoriasis</StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="Yes"/><StudyType21 name="analysis" chosen="No"/><StudyType21 name="individual_sequencing" chosen="No"/><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="Yes"><StudyType22 name="geo"/></StudyType21><StudyType21 name="subject_samples" chosen="Yes"><StudyType22 name="rna"/></StudyType21><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><StudyTypes><StudyType>phenotype_data</StudyType><StudyType>genotype_data</StudyType><StudyType>rna</StudyType><StudyType>geo</StudyType></StudyTypes></StudyInfo><Authority><ICs><IC id="18" name="NIAMS" is_funding_ic="false" is_admin_ic="true" primary="true"/></ICs><Persons><Person nedid="JGKRUEGER" aid="2" auth="eRA" login="JGKRUEGER" fname="JAMES" mname="" lname="KRUEGER" email="kruegej@rockefeller.edu"><Role allow_direct_access="true">PI</Role><Organization>ROCKEFELLER UNIVERSITY</Organization></Person><Person aid="8" auth="virtual" fname="Anton" lname="Glueck" email="anton.glueck@novartis.com"><Role>PI_ASSIST</Role><Organization/></Person><Person nedid="0010579723" aid="1" auth="cit" login="wewu" fname="Wenyu" mname="" lname="Wu" email="wwu@ncbi.nlm.nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0011559580" aid="1" auth="cit" login="stefanov" fname="Stefan" mname="Alexandrov" lname="Stefanov" email="stefanov@mail.nih.gov"><Role>GENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="2001435773" aid="1" auth="cit" login="kirilushaag" fname="Anthony" mname="G" lname="Kirilusha" email="anthony.kirilusha@nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="true" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="none"><acknowledgement_statement>The data for this &#8220;Microarray Gene Expression Data from Early Skin Biopsies of a Secukinumab Clinical Trial in Psoriasis&#8221; data set were provided by Anton Glueck, Novartis Institutes for BioMedical Research. Funding support for the original study was provided by Novartis Pharmaceuticals. For additional information please refer to the forthcoming publication by James G. Krueger et al., to be submitted to the Journal of Allergy and Clinical Immunology.</acknowledgement_statement><ic_specific_access_term/><DUC universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC><DUC_PDF universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC_PDF><GSR_Access gsr_mode="unrest_access_by_timeout" gsr_mode_label="Unrestricted access (institution did not respond within six months)"/><ConsentGroup uid="3140" CGType="cg_class_DS" title="Disease-Specific (Psoriasis and related diseases, NPU)" name="DS-PSO-RD-NPU" dac_uid="61" dac_name="NIAMS" irb-approval-required="No"><Use-Restriction>Use of the data must be related to Psoriasis and related diseases.
Use of the data is limited to not-for-profit organizations.

Use of the data is limited to Psoriasis and related diseases.  For this study, related diseases are considered to be immune-mediated skin diseases.  </Use-Restriction></ConsentGroup></Policy><SRA/><Documents/><Status uid="1" name="released" title="Released"/></Study></dbgapss>